treatment metastatic medullary thyroid cancer Archives

FDA approved thyroid cancer drug tested by TGen

by in Bioscience | Featured | Healthcare

The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). The U.S. Food and Drug Administration approved cabozantinib for the treatment of progressive, metastatic medullary thyroid cancer (MTC), a rare endocrine gland cancer affecting the… Read More →